UKMi Q&A xx - SPS

Eick-Cost et al (2017) compared neuropsychiatric outcomes in subjects prescribed mefloquine with outcomes in those prescribed doxycycline or atovaquone-proguanil, in both deployed and non-deployed groups. The risk period included the duration of the prescription and 365 days after the end of the prescription. ................
................